Putting lab results into EHRs will clearly enrich data. However, CLIA and state laws pose a barrier that should be reconsidered.
According to the American Clinical Laboratory Assn., lab results influence more than 70% of clinical decisions. Putting those results in electronic health records (EHRs) will clearly enrich the data available for physicians, hospitals, health plans and patients. This enriched data enhances the value of EHRs for treatment, quality improvement, disease management and wellness.
But the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and the state laws implementing CLIA pose barriers to clinical labs providing that data for EHRs. Those barriers are not often discussed but are a legal challenge to populating EHRs with results from clinical labs.
CLIA is a federal law that regulates the operations of clinical labs. Among other things, CLIA limits to whom a clinical lab may release the results of tests. An "authorized person" is one permitted recipient of those results. CLIA defines an authorized person as an "individual authorized under state law to order tests or receive test results, or both."
That means a variety of state laws in silent states must be reviewed to determine who is permitted to receive results from clinical labs. For example, physicians order lab tests, so under a silent state's medical practice act, physicians in that state would thus qualify under CLIA to receive results from a clinical lab.
Some states allow clinical labs to release results to patients, but most don't. In fact, several states expressly prohibit clinical labs from releasing results to patients. This contrasts with most other laws that regulate health information disclosure. Those laws, like the HIPAA Privacy Rule, give patients near absolute right to their health information.
Under the CLIA scheme then, clinical labs usually cannot release the results of tests for EHRs, except as directed by the ordering clinician or other authorized person. That constrains the ability of non-ordering clinicians, institutional providers, health plans, patients and others to receive lab results to populate EHRs.
NOT A BARRIER TO EVERYONE
The CLIA laws only regulate clinical labs, so they are not a barrier to all who hold lab results. If a non-ordering clinician, institutional provider, health plan or other non-lab party already has the lab results, CLIA and its state implementing laws do not regulate their releasing the results to populate EHRs.
Tennessee took legislative action in 2007 to ease the CLIA barrier by permitting clinical labs to release results to entities that assist providers, payers or patients in creating EHRs. The laws do not need to pose a continuing barrier.
It remains unclear what happens next for CLIA-whether other states will follow Tennessee's lead or whether the Department of Health and Human Services (HHS) will revisit CLIA and its implications for putting lab results in EHRs. HHS revision of the CLIA regulations is the way to go if the federal government is serious about promoting robust, effective EHRs.
Kathryn A. Roe is a partner in the Health Law Practice Group at Neal, Gerber & Eisenberg LLP.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More